ATE194652T1 - Menschlicher und murin-interleukin-5-rezeptor - Google Patents

Menschlicher und murin-interleukin-5-rezeptor

Info

Publication number
ATE194652T1
ATE194652T1 AT91308309T AT91308309T ATE194652T1 AT E194652 T1 ATE194652 T1 AT E194652T1 AT 91308309 T AT91308309 T AT 91308309T AT 91308309 T AT91308309 T AT 91308309T AT E194652 T1 ATE194652 T1 AT E194652T1
Authority
AT
Austria
Prior art keywords
receptor
interleukin
human
murine
murino
Prior art date
Application number
AT91308309T
Other languages
English (en)
Inventor
Kiyoshi Takatsu
Akira Tominaga
Satoshi Takagi
Yoshiyuki Murata
Original Assignee
Kiyoshi Takatsu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kiyoshi Takatsu filed Critical Kiyoshi Takatsu
Application granted granted Critical
Publication of ATE194652T1 publication Critical patent/ATE194652T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91308309T 1990-09-11 1991-09-11 Menschlicher und murin-interleukin-5-rezeptor ATE194652T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24063890 1990-09-11

Publications (1)

Publication Number Publication Date
ATE194652T1 true ATE194652T1 (de) 2000-07-15

Family

ID=17062477

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91308309T ATE194652T1 (de) 1990-09-11 1991-09-11 Menschlicher und murin-interleukin-5-rezeptor

Country Status (8)

Country Link
US (4) US5453491A (de)
EP (1) EP0475746B1 (de)
JP (1) JP2749730B2 (de)
AT (1) ATE194652T1 (de)
DE (1) DE69132306T2 (de)
DK (1) DK0475746T3 (de)
ES (1) ES2149156T3 (de)
GR (1) GR3034525T3 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW280833B (de) * 1990-12-27 1996-07-11 Hoffmann La Roche
EP0533006A1 (de) * 1991-09-18 1993-03-24 F.Hoffmann-La Roche & Co. Aktiengesellschaft Chimäre Interleukin 5-Rezeptor/Immunoglobulin-Polypeptide
DE4317577A1 (de) * 1993-05-27 1994-12-01 Boehringer Ingelheim Int Verfahren zum Screenen von Substanzen mit modulierender Wirkung auf einen Interleukin-5-Rezeptor-abhängigen zellulären Signalübertragungsweg
US6806061B1 (en) 1995-01-19 2004-10-19 Children's Medical Center Corporation G protein-coupled receptor gene and methods of use therefor
US6537764B1 (en) 1995-01-19 2003-03-25 Children's Medical Center Corporation Method of identifying inhibitors of C—C chemokine receptor 3
EP0733362A1 (de) * 1995-03-08 1996-09-25 Environmental Research Institute, Inc. Polynactine als antiallergische Mittel und IL-5-Hemmer
US5668110A (en) * 1995-06-07 1997-09-16 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
US5677280A (en) * 1995-06-07 1997-10-14 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5683983A (en) * 1995-06-07 1997-11-04 Glaxo Group Limited Peptides and compounds that bind to the IL-5 receptor
US5654276A (en) * 1995-06-07 1997-08-05 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor
ES2233974T3 (es) * 1995-09-11 2005-06-16 Kyowa Hakko Kogyo Co., Ltd. Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana.
US20020090682A1 (en) * 1995-10-23 2002-07-11 Tracy Willson Novel haemopoietin receptor and genetic sequences encoding same
US7074397B1 (en) * 1996-01-08 2006-07-11 Genentech, Inc. Method for enhancing proliferation or differentiation of a cell using ob protein
US6541604B1 (en) * 1996-01-08 2003-04-01 Genentech, Inc. Leptin receptor having a WSX motif
US20050019325A1 (en) * 1996-01-08 2005-01-27 Carter Paul J. WSX receptor agonist antibodies
US5861279A (en) * 1996-01-17 1999-01-19 Schering Corporation Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists
JP3423842B2 (ja) * 1996-01-19 2003-07-07 日研化学株式会社 変異株及び該変異株又は親株を用いるエリスリトールの製造方法
US20060205660A1 (en) * 1996-06-20 2006-09-14 Sauvage Frederic D OB protein-immunoglobulin chimeras
US6743604B1 (en) * 1996-12-13 2004-06-01 Smithkline Beecham Corporation Substances and their uses
CA2704600C (en) * 1999-04-09 2016-10-25 Kyowa Kirin Co., Ltd. A method for producing antibodies with increased adcc activity
US7109299B1 (en) 1999-12-16 2006-09-19 Affymax, Inc. Peptides and compounds that bind to the IL-5 receptor
EP1176200A3 (de) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
WO2005047327A2 (en) 2003-11-12 2005-05-26 Biogen Idec Ma Inc. NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO
JP4954709B2 (ja) * 2004-10-28 2012-06-20 協和発酵キリン株式会社 子宮内膜症治療剤
EP1838736B1 (de) 2005-01-05 2013-03-06 Biogen Idec MA Inc. Cripto-bindende moleküle
EP1957541A2 (de) * 2005-11-21 2008-08-20 Laboratoires Serono SA Zusammensetzungen und verfahren zur herstellung von antigenbindenden hybridmolekülen und anwendungen davon
TW201217527A (en) 2010-07-09 2012-05-01 Biogen Idec Hemophilia Inc Processable single chain molecules and polypeptides made using same
WO2013012733A1 (en) 2011-07-15 2013-01-24 Biogen Idec Ma Inc. Heterodimeric fc regions, binding molecules comprising same, and methods relating thereto
US9676849B2 (en) 2012-01-10 2017-06-13 Biogen Ma Inc. Enhancement of transport of therapeutic molecules across the blood brain barrier
WO2014144549A1 (en) 2013-03-15 2014-09-18 Biogen Idec Ma Inc. Factor ix polypeptide formulations
CA3191031A1 (en) 2013-09-27 2015-04-02 Massachusetts Institute Of Technology Carrier-free biologically-active protein nanostructures
US11077132B2 (en) 2015-02-04 2021-08-03 F. Hoffmann-La Roche Ag Tau antisense oligomers and uses thereof
CN115181778A (zh) 2015-02-04 2022-10-14 百时美施贵宝公司 选择治疗性分子的方法
WO2017027843A1 (en) 2015-08-12 2017-02-16 Massachusetts Institute Of Technology Cell surface coupling of nanoparticles
CN109715196A (zh) 2016-06-13 2019-05-03 转矩医疗股份有限公司 用于促进免疫细胞功能的组合物和方法
CA3074826A1 (en) 2017-09-05 2019-03-14 Torque Therapeutics, Inc. Therapeutic protein compositions and methods of making and using the same
CN118251407A (zh) * 2021-09-22 2024-06-25 索诺玛生物治疗公司 Il5ra细胞表面标记物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006459A (en) * 1986-03-31 1991-04-09 T Cell Sciences, Inc. Therapeutic and diagnostic methods using soluble T cell surface molecules
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
CA1341152C (en) * 1988-01-22 2000-12-12 Tadamitsu Kishimoto Receptor protein for human b cell stimulatory factor-2
AU643427B2 (en) * 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
CA2007305A1 (en) * 1989-01-09 1990-07-09 Nicole Suciu-Foca Differentiation antigen, nda4, associated with the receptor for b cell growth factor
TW280833B (de) * 1990-12-27 1996-07-11 Hoffmann La Roche

Also Published As

Publication number Publication date
US5807991A (en) 1998-09-15
DK0475746T3 (da) 2000-10-30
DE69132306T2 (de) 2001-03-01
US5453491A (en) 1995-09-26
DE69132306D1 (de) 2000-08-17
EP0475746A1 (de) 1992-03-18
US5760204A (en) 1998-06-02
JP2749730B2 (ja) 1998-05-13
JPH0654690A (ja) 1994-03-01
US5916767A (en) 1999-06-29
EP0475746B1 (de) 2000-07-12
GR3034525T3 (en) 2000-12-29
ES2149156T3 (es) 2000-11-01

Similar Documents

Publication Publication Date Title
DE69132306D1 (de) Menschlicher und Murin-Interleukin-5-Rezeptor
IT206947Z2 (it) Sedia con schienale articolato
IL119462A0 (en) Pyrrolopyrimidines
DE3882593D1 (de) Polypeptid und dessen herstellung.
DE3766533D1 (de) Kinderlaufstuhl.
DE3863451D1 (de) Zusammenklappbarer kinderstuhl.
FI916067A7 (fi) Ihmisen interleukiini 5-reseptori
IT1189308B (it) L'impiego in terapeutica d'un derivato dell'acetammide
FR2615369B1 (fr) Chaise-canne
IT8335696V0 (it) Poltrona con spalliera, sedile e poggiapiedi movibili comandati e posizionati dal corpo dell'occupante
IT1232070B (it) Schienale per sedie e simili con regolazione del profilo dell'imbottitura
DE3875807D1 (de) 3-acylaminomethyl-5,6,7,8-tetrahydroimidazo(1,2-a)pyridinderivate, ihre herstellung und therapeutische verwendung.
Strnad The transduction of inflammatory stimuli in human neutrophils
KR890012477U (ko) 보온 의자
BR6700348U (pt) Cadeira articulada com inclinacao regulavel
BR6700627U (pt) Cadeira e mesa articuladas desmontaveis
KR890000228U (ko) 좌욕 의자
ES1001804Y (es) Soporte perfeccionado para el acoplamiento amovible de barandillas frontales en coches-silla infantiles
BR6700879U (pt) Disposicao construtiva em cadeira para criancas
BR6700349U (pt) Cadeira de assento regulavel
ES293964Y (es) Reposapies mejorado para coches-silla infantiles
SE8704367D0 (sv) Infellbara barnseteskonstruktion for personbilars ryggstod
BR6101770U (pt) Cadeira odontologica com encosto vibratorio
BR6100363U (pt) Cadeirinha sanitaria para criancas
BR6700740U (pt) Assento ortopedico

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time